GlaxoSmithKline Pharmaceuticals Ltd (GSK India), a subsidiary of GlaxoSmithKline Plc, which operates across pharmaceuticals, vaccines and consumer health domains. Its product portfolio into two categories, namely, prescription medicines, specialty medicines and vaccines. The prescription medicines include therapeutic areas such as anti-infectives, oncology, dermatology, gynecology, diabetes, cardiovascular disease, HIV and respiratory diseases.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

GSK India’s research and development activities focuses on discovering medicines and innovative pipeline of vaccines related to the immune system and use of genetics with advanced technologies. It has been focusing on major therapy areas includes infectious diseases, HIV, oncology, respiratory and immunology. The company constantly improving respiratory related medicines and working to complete cure for inflammatory diseases. It has 300,000 healthcare professionals. It has one manufacturing facility in Nashik, Maharashtra. The company spent INR19.1 million on research and development in FY2023, which as a percentage of revenue stood at 0.1%.